Neurochemical Research

, Volume 39, Issue 7, pp 1338–1345 | Cite as

Effects of Aluminium on β-Amyloid (1–42) and Secretases (APP-Cleaving Enzymes) in Rat Brain

  • Linping Wang
  • Jiali Hu
  • Yue Zhao
  • Xiaoting Lu
  • Qinli Zhang
  • Qiao NiuEmail author
Original Paper


Chronic administration of aluminium has been proposed as an environmental factor that may affect some pathological changes related to neurotoxicity and Alzheimer’s disease (AD). The abnormal generation and deposition of β-amyloid (Aβ) in senile plaques are hallmark features in the brains of AD patients. Furthermore, Aβ is generated by the sequential cleavage of the amyloid precursor protein (APP) via the APP cleaving enzyme (α-secretase, or β-secretase) and γ-secretase. In the present study, we investigated the modulation of Aβ deposition and neurotoxicity in aluminium-maltolate-treated (0, 15, 30, 45 mmol/kg body weight via intraperitoneal injection) in experimental rats. We measured Aβ1–40 and Aβ1–42 in the cortex and hippocampus in rat brains using ELISA. Subtypes of α-secretase, β-secretase, and γ-secretase, including ADAM9, ADAM10, ADAM17 (TACE), BACE1, presenilin 1 (PS1) and nicastrin (NCT), were determined using western blotting analyses. These results indicated that aluminium-maltolate induced an AD-like behavioural deficit in rats at 30 and 45 mmol/kg body weight. Moreover, the Aβ1–42 content increased significantly, both in the cortex and hippocampus, although no changes were observed in Aβ1–40. Furthermore, ADAM9, ADAM10, and ADAM17 decreased significantly; in contrast, BACE1, PS1, and NCT showed significant increase. Taken together, these results suggest that the changes in secretases may correlate to the abnormal deposition of Aβ by aluminium in rat brains.


Aluminium β-Amyloid α-Secretase β-Secretase γ-Secretase 



This work was supported by the National Nature Science Foundation of China (81302410).


  1. 1.
    Wu G, Sankaranarayanan S, Hsieh SH, Simon AJ, Savage MJ (2011) Decrease in brain soluble amyloid precursor protein beta (sAPPbeta) in Alzheimer’s disease cortex. J Neurosci Res 89:822–832PubMedCrossRefGoogle Scholar
  2. 2.
    Jiang T, Zhi XL, Zhang YH, Pan LF, Zhou P (2012) Inhibitory effect of curcumin on the Al(III)-induced Abeta(4)(2) aggregation and neurotoxicity in vitro. Biochim Biophys Acta 1822:1207–1215PubMedCrossRefGoogle Scholar
  3. 3.
    Castorina A, Tiralongo A, Giunta S, Carnazza ML, Scapagnini G, D’Agata V (2010) Early effects of aluminum chloride on beta-secretase mRNA expression in a neuronal model of beta-amyloid toxicity. Cell Biol Toxicol 26:367–377PubMedCrossRefGoogle Scholar
  4. 4.
    Cleary JP, Walsh DM, Hofmeister JJ, Shankar GM, Kuskowski MA, Selkoe DJ, Ashe KH (2005) Natural oligomers of the amyloid-beta protein specifically disrupt cognitive function. Nat Neurosci 8:79–84PubMedCrossRefGoogle Scholar
  5. 5.
    Banks WA, Niehoff ML, Drago D, Zatta P (2006) Aluminum complexing enhances amyloid beta protein penetration of blood-brain barrier. Brain Res 1116:215–221PubMedCrossRefGoogle Scholar
  6. 6.
    Walton JR (2013) Aluminum involvement in the progression of Alzheimer’s disease. J Alzheimers Dis (JAD) 35:7–43Google Scholar
  7. 7.
    Brenner S (2013) Aluminum may mediate Alzheimer’s disease through liver toxicity, with aberrant hepatic synthesis of ceruloplasmin and ATPase7B, the resultant excess free copper causing brain oxidation, beta-amyloid aggregation and Alzheimer disease. Med Hypotheses 80:326–327PubMedCrossRefGoogle Scholar
  8. 8.
    Walton JR (2012) Cognitive deterioration and associated pathology induced by chronic low-level aluminum ingestion in a translational rat model provides an explanation of Alzheimer’s disease, tests for susceptibility and avenues for treatment. Int J Alzheimers Dis 2012:914947PubMedCentralPubMedGoogle Scholar
  9. 9.
    Liang RF, Li WQ, Wang XH, Zhang HF, Wang H, Wang JX, Zhang Y, Wan MT, Pan BL, Niu Q (2012) Aluminium-maltolate-induced impairment of learning, memory and hippocampal long-term potentiation in rats. Ind Health 50:428–436PubMedCrossRefGoogle Scholar
  10. 10.
    Ferreira PC, Piai Kde A, Takayanagui AM, Segura-Munoz SI (2008) Aluminum as a risk factor for Alzheimer’s disease. Rev Lat Am Enfermagem 16:151–157PubMedCrossRefGoogle Scholar
  11. 11.
    Ricchelli F, Drago D, Filippi B, Tognon G, Zatta P (2005) Aluminum-triggered structural modifications and aggregation of beta-amyloids. Cell Mol Life Sci (CMLS) 62:1724–1733CrossRefGoogle Scholar
  12. 12.
    Drago D, Folin M, Baiguera S, Tognon G, Ricchelli F, Zatta P (2007) Comparative effects of Abeta(1-42)-Al complex from rat and human amyloid on rat endothelial cell cultures. J Alzheimers Dis (JAD) 11:33–44Google Scholar
  13. 13.
    Zaky A, Mohammad B, Moftah M, Kandeel KM, Bassiouny AR (2013) Apurinic/apyrimidinic endonuclease 1 is a key modulator of aluminum-induced neuroinflammation. BMC Neurosci 14:26PubMedCentralPubMedCrossRefGoogle Scholar
  14. 14.
    Fiorelli T, Kirouac L, Padmanabhan J (2013) Altered processing of amyloid precursor protein in cells undergoing apoptosis. PLoS One 8:e57979PubMedCentralPubMedCrossRefGoogle Scholar
  15. 15.
    Deuss M, Reiss K, Hartmann D (2008) Part-time alpha-secretases: the functional biology of ADAM 9, 10 and 17. Curr Alzheimer Res 5:187–201PubMedCrossRefGoogle Scholar
  16. 16.
    Allinson TM, Parkin ET, Turner AJ, Hooper NM (2003) ADAMs family members as amyloid precursor protein alpha-secretases. J Neurosci Res 74:342–352PubMedCrossRefGoogle Scholar
  17. 17.
    Lichtenthaler SF (2011) Alpha-secretase in Alzheimer’s disease: molecular identity, regulation and therapeutic potential. J Neurochem 116:10–21PubMedCrossRefGoogle Scholar
  18. 18.
    Esch FS, Keim PS, Beattie EC, Blacher RW, Culwell AR, Oltersdorf T, McClure D, Ward PJ (1990) Cleavage of amyloid beta peptide during constitutive processing of its precursor. Science (New York, NY) 248:1122–1124CrossRefGoogle Scholar
  19. 19.
    Roberts SB, Ripellino JA, Ingalls KM, Robakis NK, Felsenstein KM (1994) Non-amyloidogenic cleavage of the beta-amyloid precursor protein by an integral membrane metalloendopeptidase. J Biol Chem 269:3111–3116PubMedGoogle Scholar
  20. 20.
    Lammich S, Kojro E, Postina R, Gilbert S, Pfeiffer R, Jasionowski M, Haass C, Fahrenholz F (1999) Constitutive and regulated alpha-secretase cleavage of Alzheimer’s amyloid precursor protein by a disintegrin metalloprotease. Proc Natl Acad Sci USA 96:3922–3927PubMedCentralPubMedCrossRefGoogle Scholar
  21. 21.
    Delarasse C, Auger R, Gonnord P, Fontaine B, Kanellopoulos JM (2011) The purinergic receptor P2X7 triggers alpha-secretase-dependent processing of the amyloid precursor protein. J Biol Chem 286:2596–2606PubMedCentralPubMedCrossRefGoogle Scholar
  22. 22.
    Frykman S, Hur JY, Franberg J, Aoki M, Winblad B, Nahalkova J, Behbahani H, Tjernberg LO (2010) Synaptic and endosomal localization of active gamma-secretase in rat brain. PLoS One 5:e8948PubMedCentralPubMedCrossRefGoogle Scholar
  23. 23.
    Smolarkiewicz M, Skrzypczak T, Wojtaszek P (2013) The very many faces of presenilins and the γ-secretase complex. Protoplasma 250:997–1011Google Scholar
  24. 24.
    Dries DR, Yu G (2008) Assembly, maturation, and trafficking of the gamma-secretase complex in Alzheimer’s disease. Curr Alzheimer Res 5:132–146PubMedCentralPubMedCrossRefGoogle Scholar
  25. 25.
    Caccamo A, Oddo S, Sugarman MC, Akbari Y, LaFerla FM (2005) Age- and region-dependent alterations in Abeta-degrading enzymes: implications for Abeta-induced disorders. Neurobiol Aging 26:645–654PubMedCrossRefGoogle Scholar
  26. 26.
    Langui D, Probst A, Anderton B, Brion JP, Ulrich J (1990) Aluminium-induced tangles in cultured rat neurones. Enhanced effect of aluminium by addition of maltol. Acta Neuropathol 80:649–655PubMedCrossRefGoogle Scholar
  27. 27.
    Flaten TP (2001) Aluminium as a risk factor in Alzheimer’s disease, with emphasis on drinking water. Brain Res Bull 55:187–196PubMedCrossRefGoogle Scholar
  28. 28.
    Martyn CN (1992) The epidemiology of Alzheimer’s disease in relation to aluminium. Ciba Found Symp Ciba 169:69–79 discussion 79–86Google Scholar
  29. 29.
    Chen TJ, Hung HS, Wang DC, Chen SS (2010) The protective effect of Rho-associated kinase inhibitor on aluminum-induced neurotoxicity in rat cortical neurons. Toxicol Sci 116:264–272PubMedCrossRefGoogle Scholar
  30. 30.
    Bhalla P, Dhawan DK (2009) Protective role of lithium in ameliorating the aluminium-induced oxidative stress and histological changes in rat brain. Cell Mol Neurobiol 29:513–521PubMedCrossRefGoogle Scholar
  31. 31.
    Kaur A, Joshi K, Minz RW, Gill KD (2006) Neurofilament phosphorylation and disruption: a possible mechanism of chronic aluminium toxicity in Wistar rats. Toxicology 219:1–10PubMedCrossRefGoogle Scholar
  32. 32.
    Campbell A, Kumar A, La Rosa FG, Prasad KN, Bondy SC (2000) Aluminum increases levels of beta-amyloid and ubiquitin in neuroblastoma but not in glioma cells. Proc Soc Exp Biol Med (New York, NY) 223:397–402CrossRefGoogle Scholar
  33. 33.
    Yumoto S, Kakimi S, Ohsaki A, Ishikawa A (2009) Demonstration of aluminum in amyloid fibers in the cores of senile plaques in the brains of patients with Alzheimer’s disease. J Inorg Biochem 103:1579–1584PubMedCrossRefGoogle Scholar
  34. 34.
    Pratico D, Uryu K, Sung S, Tang S, Trojanowski JQ, Lee VM (2002) Aluminum modulates brain amyloidosis through oxidative stress in APP transgenic mice. FASEB J 16:1138–1140PubMedGoogle Scholar
  35. 35.
    Sun ZZ, Chen ZB, Jiang H, Li LL, Li EG, Xu Y (2009) Alteration of Abeta metabolism-related molecules in predementia induced by AlCl3 and D-galactose. Age 31:277–284PubMedCentralPubMedCrossRefGoogle Scholar
  36. 36.
    Marcinkiewicz M, Seidah NG (2000) Coordinated expression of beta-amyloid precursor protein and the putative beta-secretase BACE and alpha-secretase ADAM10 in mouse and human brain. J Neurochem 75:2133–2143PubMedCrossRefGoogle Scholar
  37. 37.
    Skovronsky DM, Fath S, Lee VM, Milla ME (2001) Neuronal localization of the TNFalpha converting enzyme (TACE) in brain tissue and its correlation to amyloid plaques. J Neurobiol 49:40–46PubMedCrossRefGoogle Scholar
  38. 38.
    Harada H, Tamaoka A, Ishii K, Shoji S, Kametaka S, Kametani F, Saito Y, Murayama S (2006) Beta-site APP cleaving enzyme 1 (BACE1) is increased in remaining neurons in Alzheimer’s disease brains. Neurosci Res 54:24–29PubMedCrossRefGoogle Scholar
  39. 39.
    Zhao J, Fu Y, Yasvoina M, Shao P, Hitt B, O’Connor T, Logan S, Maus E, Citron M, Berry R, Binder L, Vassar R (2007) Beta-site amyloid precursor protein cleaving enzyme 1 levels become elevated in neurons around amyloid plaques: implications for Alzheimer’s disease pathogenesis. J Neurosci 27:3639–3649PubMedCrossRefGoogle Scholar
  40. 40.
    Tamagno E, Parola M, Bardini P, Piccini A, Borghi R, Guglielmotto M, Santoro G, Davit A, Danni O, Smith MA, Perry G, Tabaton M (2005) Beta-site APP cleaving enzyme up-regulation induced by 4-hydroxynonenal is mediated by stress-activated protein kinases pathways. J Neurochem 92:628–636PubMedCrossRefGoogle Scholar
  41. 41.
    Li Q, Sudhof TC (2004) Cleavage of amyloid-beta precursor protein and amyloid-beta precursor-like protein by BACE 1. J Biol Chem 279:10542–10550PubMedCrossRefGoogle Scholar
  42. 42.
    Gustaw KA, Garrett MR, Lee HG, Castellani RJ, Zagorski MG, Prakasam A, Siedlak SL, Zhu X, Perry G, Petersen RB, Friedland RP, Smith MA (2008) Antigen-antibody dissociation in Alzheimer disease: a novel approach to diagnosis. J Neurochem 106:1350–1356PubMedCentralPubMedCrossRefGoogle Scholar
  43. 43.
    Panahi N, Mahmoudian M, Mortazavi P, Hashjin GS (2013) Effects of berberine on beta-secretase activity in a rabbit model of Alzheimer’s disease. Arch Med Sci (AMS) 9:146–150CrossRefGoogle Scholar
  44. 44.
    Hass MR, Sato C, Kopan R, Zhao G (2009) Presenilin: RIP and beyond. Semin Cell Dev Biol 20:201–210PubMedCentralPubMedCrossRefGoogle Scholar
  45. 45.
    Chen F, Yu G, Arawaka S, Nishimura M, Kawarai T, Yu H, Tandon A, Supala A, Song YQ, Rogaeva E, Milman P, Sato C, Yu C, Janus C, Lee J, Song L, Zhang L, Fraser PE, St George-Hyslop PH (2001) Nicastrin binds to membrane-tethered Notch. Nat Cell Biol 3:751–754PubMedCrossRefGoogle Scholar
  46. 46.
    Dries DR, Shah S, Han YH, Yu C, Yu S, Shearman MS, Yu G (2009) Glu-333 of nicastrin directly participates in gamma-secretase activity. J Biol Chem 284:29714–29724PubMedCentralPubMedCrossRefGoogle Scholar
  47. 47.
    Pasternak SH, Bagshaw RD, Guiral M, Zhang S, Ackerley CA, Pak BJ, Callahan JW, Mahuran DJ (2003) Presenilin-1, nicastrin, amyloid precursor protein, and gamma-secretase activity are co-localized in the lysosomal membrane. J Biol Chem 278:26687–26694PubMedCrossRefGoogle Scholar
  48. 48.
    LaVoie MJ, Fraering PC, Ostaszewski BL, Ye W, Kimberly WT, Wolfe MS, Selkoe DJ (2003) Assembly of the gamma-secretase complex involves early formation of an intermediate subcomplex of Aph-1 and nicastrin. J Biol Chem 278:37213–37222PubMedCrossRefGoogle Scholar
  49. 49.
    Zhang YW, Luo WJ, Wang H, Lin P, Vetrivel KS, Liao F, Li F, Wong PC, Farquhar MG, Thinakaran G, Xu H (2005) Nicastrin is critical for stability and trafficking but not association of other presenilin/gamma-secretase components. J Biol Chem 280:17020–17026PubMedCentralPubMedCrossRefGoogle Scholar
  50. 50.
    Mao G, Cui MZ, Li T, Jin Y, Xu X (2012) Pen-2 is dispensable for endoproteolysis of presenilin 1, and nicastrin-Aph subcomplex is important for both gamma-secretase assembly and substrate recruitment. J Neurochem 123:837–844PubMedCentralPubMedCrossRefGoogle Scholar
  51. 51.
    Sesele K, Thanopoulou K, Paouri E, Tsefou E, Klinakis A, Georgopoulos S (2013) Conditional inactivation of nicastrin restricts amyloid deposition in an Alzheimer’s disease mouse model. Aging cell 12:1032–1040Google Scholar

Copyright information

© Springer Science+Business Media New York 2014

Authors and Affiliations

  • Linping Wang
    • 1
  • Jiali Hu
    • 1
  • Yue Zhao
    • 1
  • Xiaoting Lu
    • 1
  • Qinli Zhang
    • 1
  • Qiao Niu
    • 1
    Email author
  1. 1.School of Public HealthShanxi Medical UniversityTaiyuanChina

Personalised recommendations